Catalyst Pharmaceuticals Funding: $86M Raised, IPO

Catalyst Pharmaceuticals funding overview

Catalyst Pharmaceuticals is based in Coral Gables, Florida. Catalyst Pharmaceuticals has raised $86M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an IPO. Investors on record include Baker Brothers Advisors, Point72 Asset Management, Consonance Capital Management, Broadfin Capital, Federated Kauffman Fund. 5 distinct backers are named across the disclosed rounds.

Catalyst Pharmaceuticals at a glance

Total raised: $86M
Latest round: IPO
Headquarters: Coral Gables, Florida
Notable investors: Baker Brothers Advisors, Point72 Asset Management, Consonance Capital Management, Broadfin Capital, Federated Kauffman Fund

Frequently asked about Catalyst Pharmaceuticals funding

How much has Catalyst Pharmaceuticals raised?: Catalyst Pharmaceuticals has raised $86M in total disclosed funding across the rounds on record.
Who has invested in Catalyst Pharmaceuticals?: Baker Brothers Advisors, Point72 Asset Management, Consonance Capital Management, Broadfin Capital, Federated Kauffman Fund are named among the investors backing Catalyst Pharmaceuticals.
What was the latest Catalyst Pharmaceuticals funding round?: The most recent disclosed round is an IPO.
Where is Catalyst Pharmaceuticals based?: Catalyst Pharmaceuticals is based in Coral Gables, Florida.

Every Catalyst Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Coral Gables at a similar stage.

Catalyst Pharmaceuticals Funding: $86M Raised, IPO

Catalyst Pharmaceuticals funding overview

Catalyst Pharmaceuticals at a glance

Frequently asked about Catalyst Pharmaceuticals funding

Companies related to Catalyst Pharmaceuticals (35)

Browse related funding lists (2)